Rentokil Initial PLC's stock plummeted 9.34% in pre-market trading on Thursday, following concerns raised by analysts at J.P. Morgan that the company's 2027 margin guidance might be too ambitious.
According to the analysts, while investors may be relieved that Rentokil has confirmed 2025 consensus expectations, the company's goal of a 20% increase in margins for its North American operations "might be difficult to reach, unless growth surprises materially on the upside."
The analysts note that while Rentokil should be able to achieve the margins guidance over time, the timeline for the North America margin target appears ambitious based on current projections.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。